Dr. Kalunian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
San Diego, CA 92103Phone+1 800-926-8273Fax+1 888-539-8781
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Rheumatology, 1983 - 1985
- Olive View/UCLA Medical CenterResidency, Internal Medicine, 1979 - 1983
- Saint Louis University School of MedicineClass of 1979
Certifications & Licensure
- CA State Medical License 1980 - 2026
- American Board of Internal Medicine Internal Medicine
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST) Start of enrollment: 2005 Sep 01
- Using Ultrasonography to Predict Clinical Response to Intraarticular Corticosteroids in Knee Osteoarthritis Start of enrollment: 2005 Dec 01
- Using Ultrasound to Predict Response to Intraarticular Corticosteroids in Knee Osteoarthritis Start of enrollment: 2004 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Placebo Effect Sizes are Larger in Clinical Trials of Knee Osteoarthritis using Intra-Articular Injections of Biologic Agents.Johanna M Borst, Severin Ruoss, Ian Palmer, Trevor Smith, Kenneth Kalunian
Arthritis Care & Research. 2025-03-19 - 2 citationsExtrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network.Philip M Carlucci, Katherine Preisinger, Kristina K Deonaraine, Devyn Zaminski, Maria Dall'Era
Rheumatology. 2025-03-01 - Part A of the LILAC study of litifilimab for systemic lupus erythematosus: a plain language summary.Richard A Furie, Ronald F van Vollenhoven, Kenneth Kalunian, Sandra Navarra, Juanita Romero-Diaz
Immunotherapy. 2025-02-24
Journal Articles
- Psychosis in Systemic Lupus ErythematosusAnca Askanase, Kenneth C Kalunian, M A Dooley, Meggan Mackay, Ellen M Ginzler, Daniel J Wallace, Susan Manzi, Cynthia Aranow, Joan T Merrill, Michelle Petri, Diane L K..., Arthritis & Rheumatology
Other
- Clinical manifestations of osteoarthritisKalunian KC
http://www.uptodate.com/contents/clinical-manifestations-of-osteoarthritis
UpToDate, Wolters Kluwer Health - 2012-12-06 - Diagnosis and classification of osteoarthritisKalunian KC
http://www.uptodate.com/contents/diagnosis-and-classification-of-osteoarthritis
UpToDate, Wolters Kluwer Health - 2012-04-17 - Investigational approaches to the pharmacologic therapy of osteoarthritisKalunian KC
http://www.uptodate.com/contents/investigational-approaches-to-the-pharmacologic-therapy-of-osteoart
UpToDate, Wolters Kluwer Health - 2012-10-12 - Join now to see all
Authored Content
- Novel Serum and Urinary Biomarkers for Use in Diagnosis and Disease Course Management in Lupus NephritisNovember 2022
Press Mentions
- Experts Describe Strides Made in Understudied Lupus ArthritisJanuary 1st, 2025
- Two Promising Treatment Options for SLENovember 16th, 2022
- Baricitinib Helps Lupus Patients with Arthritis or Rash – Phase 2 StudyJuly 24th, 2018
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: